← All trials
NCT05207358
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 2, 2022
- Primary completion
- Dec 31, 2028
- Completion date
- Dec 31, 2028
- First posted
- Jan 26, 2022
- Last posted
- Mar 3, 2022
- Enrollment
- 30
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Institutul Clinic Fundeni, Bucarest, RomaniaLead sponsor
- Institutul Clinic Fundeni, Bucarest, RomaniaOverall official - principal investigator
- Institutul Clinic Fundeni, Bucarest, RomaniaReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.